Sorrento Therapeutics, Inc.
Antibody drug conjugates

Last updated:

Abstract:

There is disclosed a Dolastatin derivative, conjugated to an antibody, comprising a Dolastatin derivative moiety of Formula IV.

Status:
Grant
Type:

Utility

Filling date:

28 Jan 2016

Issue date:

17 Mar 2020